Questions and Answers 100%
Guaranteed Success | Already Rated A+
What is the most common cause of kidney failure?
a. diabetes
b. hypertension
c. congestive heart failure
d. glomerulonephritis - 🧠ANSWER ✔✔a. diabetes
Compromise of which body system is the leading cause of death in ESRD?
a. musculoskeletal
b. cardiovascular
c. central nervous system
d. pulmonary - 🧠ANSWER ✔✔b. cardiovascular
Which of the following is true regarding rehab for a patient with a diagnosis
of ESRD and post-stroke?
COPYRIGHT©JOSHCLAY 2025/2026. YEAR PUBLISHED 2025. COMPANY REGISTRATION NUMBER: 619652435. TERMS OF USE. PRIVACY
1
STATEMENT. ALL RIGHTS RESERVED
,a. low intensity aerobic exercise promotes the release of BDNF
b. HR and BP are accurate measures of exercise tolerance
c. exercise should be performed the day before dialysis
d. cardiorespiratory fitness decreases 50% compared to sedentary match -
🧠ANSWER ✔✔d. cardiorespiratory fitness decreases 50% compared to
sedentary match
Which of the following lists the AHA stroke guidelines for aerobic exercise?
a. 20-60 mins, 3-5x/wk, 40-70% HRR
b. 30 mins, 2-3x/wk, 40-70% HRR
c. 20-30 mins, 3-5x/wk, 40-70% HRR
d. 30-60 mins, 3-5x/wk, 50-80% HRR - 🧠ANSWER ✔✔a. 20-60 mins, 3-
5x/wk, 40-70% HRR
When exercising a patient with COPD, what RPE range should be targeted
on the modified borg scale?
a. 7-8
b. 2-3
c. 3-6
COPYRIGHT©JOSHCLAY 2025/2026. YEAR PUBLISHED 2025. COMPANY REGISTRATION NUMBER: 619652435. TERMS OF USE. PRIVACY
2
STATEMENT. ALL RIGHTS RESERVED
, d. 8-10 - 🧠ANSWER ✔✔c. 3-6
Based on the GOLD classification for COPD, a patient with an FEV1 of
65% is considered to be:
a. mild
b. moderate
c. severe
d. very severe - 🧠ANSWER ✔✔moderate
Based on the GOLD classification for COPD, a patient with an FEV1 of
25% is considered to be:
a. mild
b. moderate
c. severe
d. very severe - 🧠ANSWER ✔✔d. very severe
Based on the GOLD classification for COPD, a patient with an FEV1 of
35% is considered to be:
a. mild
COPYRIGHT©JOSHCLAY 2025/2026. YEAR PUBLISHED 2025. COMPANY REGISTRATION NUMBER: 619652435. TERMS OF USE. PRIVACY
3
STATEMENT. ALL RIGHTS RESERVED